Mode
Text Size
Log in / Sign up
N/A N=1,173 Randomized Single-blind Health Services Research

Three Strategies for Implementing Motivational Interviewing on Medical Inpatient Units

See One · Do One · Order One

Enrolled (actual)
1,173
Serious AEs
0.0%
Results posted
Mar 2021
Primary outcome: Primary: Percentage of Motivation Interviewing Sessions Audio Recorded — 0.8; 3.0; 20.5 percentage of MI sessions audio recorded — p=0.0009

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
See One (Behavioral); Do One (Behavioral); Order One (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
National Institute on Drug Abuse (NIDA)
Primary completion
Nov 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Motivation Interviewing Sessions Audio Recorded
0.8; 3.0; 20.5 0.0009 sig
SECONDARY
The Independent Tape Rater Scale - Fundamental Adherence Score
4.00; 4.60; 5.22 0.0217 sig
SECONDARY
The Independent Tape Rater Scale- Fundamental Competence Score
3.67; 4.27; 4.71 0.0091 sig
SECONDARY
The Independent Tape Rater Scale- Advanced Adherence Score
3.93; 4.38; 4.81 0.1566
SECONDARY
The Independent Tape Rater Scale- Advanced Competence Score
3.92; 4.25; 4.49 .1327
SECONDARY
Adequately Performing MI
2; 11; 100

Summary

General medical hospitals provide care for a disproportionate share of patients who misuse substances. Motivational interviewing (MI) is a well-recognized, evidenced-based substance use treatment. However, it is unclear which implementation strategies lead to the efficient and proficient uptake of MI in general medical settings, such as medical inpatient units. Because medical providers have multiple practice demands and time constraints, new practices have the greatest chance of being implemented if they are simple and compatible with existing workflows and systems. Two widely used strategies to bring specialized practices into use within general hospital settings are the apprenticeship model of training and use of consultation-liaison (CL) services. The apprenticeship model requires that appropriate patients and trainers are available with high flexibility for teaching and supervision; when applied to behavioral counseling approaches, this model may be incompatible with the providers' medical role and time constraints. In contrast, ordering MI through CL is relatively simple, minimally burdensome, and highly compatible with the way clinicians secure other specialist services for their patients in the hospital. This cluster randomized controlled trial examines the effectiveness of three different strategies for integrating MI into the practice of medical providers working within an academically affiliated internal medicine hospitalist service. Specifically, the trial randomizes 38 healthcare providers to one of three conditions: (1) a continuing medical education workshop that provides background and "shows" healthcare providers how to conduct MI (the control condition, called SEE ONE); (2) a "see one, do one" apprenticeship model involving workshop training plus live supervision of bedside practice (DO ONE); and (3) ordering MI from CL after learning about it in a workshop (ORDER ONE). Following the respective MI trainings, each healthcare provider will be assessed for the provision of MI to 40 study-eligible inpatients, recruited by the research team after admission to our general medical units. Trial hypotheses are 1) the percentage of MI sessions delivered by providers to study-eligible inpatients will be higher in both Do One and Order One than See One, and 2) providers in both Do One and Order One will conduct MI sessions with greater integrity than those in See One. This study is an implementation trial examining provider, not patient, outcomes.

Eligibility Criteria

For Healthcare provider participants:

Inclusion criteria

  • Assignment to one of the general medical inpatient units during day-time shifts; intensive care units will be excluded given the morbidity of patients in this setting.
  • Volunteer to serve as study clinicians, attend a workshop about MI, and possibly receive live supervision.
  • Agree to all procedures of this trial (randomization to training condition and of assigned patients, audio recording MI sessions, and completing assessments).

Exclusion criteria

  • Have been formally supervised to use MI with patients on the units.
  • Intend to give notice that they plan to leave the hospital or are scheduled for medical or family leave such that they will not be able to interview 40 patients during the study period.

For patient participants:

Inclusion criteria

  • Are 18 years of age or older.
  • Acknowledge use of a substance within past 28 days and meets screening criteria consistent with substance (illicit drugs, licit drugs that are used in a non-medically indicated fashion, alcohol, or nicotine) use disorder.
  • Are willing to consent to audio recording of interview with the provider or CL clinician.

Exclusion criteria

  • Have an altered mental status such as delirium, encephalopathy, dementia or mental retardation or a score on the Confusion Assessment Method > 0 since this would impair provision of consent and ability to participate
  • Inability to speak English. Most of providers are mono-lingual English speakers, and all MI integrity raters only speak English. We therefore do not have the capacity to include Spanish-only speaking patients in the study.
  • Stroke (that precludes participation)
  • Resides in a nursing home, skilled nursing facility or Hospice Care
  • Receiving palliative care
  • Deaf
  • Unable to speak lucidly
  • Previous participation in the protocol

An information sheet was requested and approved for a subset of patient subjects. This is due to the study being conducted within an acute medical inpatient unit, where conditions that might limit a person's ability to sign the consent form may occasionally occur. This subset of patients includes: patients that are physically unable to write (i.e. hand tremors, spinal cord injury, stroke that precludes signing, broken hand, broken shoulder, muscular dystrophy and other physical ailments preventing a patient from physically signing), unable to see (i.e. legally blind, uncontrolled type 2 diabetes mellitus which led to blurred vision), unable to read (i.e. patient does not have their glasses on them).

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01825057). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search